SEAN GAFFNEY: Open Payments
NPI 1659708212 · YORK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$915 in 44 payments from 8 companies in 2025. Trend: 2023 $15 · 2024 $275 · 2025 $915
Food & beverage: $910Education: $5
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $290 |
| UCB, Inc. | 13 | $175 |
| ABBVIE INC. | 6 | $173 |
| Regeneron Healthcare Solutions, Inc. | 7 | $162 |
| Novartis Pharmaceuticals Corporation | 3 | $57 |
| Organon LLC | 1 | $25 |
| Lilly USA, LLC | 1 | $19 |
| LEO Pharma Inc. | 1 | $14 |
Products named: TREMFYA, Bimzelx, DUPIXENT, RINVOQ, COSENTYX, VTAMA, TALTZ, SKYRIZI.
Industry payments across PA — which companies pay providers there.
